In vitro radiosensitization by gold nanoparticles during continuous low-dose-rate gamma irradiation with I-125 brachytherapy seeds

被引:84
作者
Ngwa, Wilfred [1 ,3 ]
Korideck, Houari [1 ]
Kassis, Amin I. [2 ]
Kumar, Rajiv [4 ,5 ]
Sridhar, Srinivas [3 ,4 ,5 ]
Makrigiorgos, G. Mike [1 ,3 ]
Cormack, Robert A. [1 ,3 ]
机构
[1] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA 02115 USA
[4] Northeastern Univ, Elect Mat Res Inst, Boston, MA 02115 USA
[5] Northeastern Univ, Dept Phys, Boston, MA 02115 USA
关键词
Gold nanoparticles; Radiosensitizers; Brachytherapy; Radiotherapy; In vitro; RADIATION-THERAPY; CANCER-THERAPY; CELL-SURVIVAL; ENHANCEMENT; DNA; DOSIMETRY; APOPTOSIS; ENERGY; FOCI;
D O I
10.1016/j.nano.2012.09.001
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
This communication reports the first experimental evidence of gold nanoparticle (AuNP) radiosensitization during continuous low-dose-rate (LDR) gamma irradiation with low-energy brachytherapy sources. HeLa cell cultures incubated with and without AuNP were irradiated with an I-125 seed plaque designed to produce a relatively homogeneous dose distribution in the plane of the cell culture slide. Four sets of irradiation experiments were conducted at low-dose rates ranging from 2.1 to 4.5 cGy/h. Residual gamma H2AX was measured 24 h after irradiation and used to compare radiation damage to the cells with and without AuNP. The data demonstrate that the biological effect when irradiating in the presence of 0.2mg/ml concentration of AuNP is about 70%-130% greater than without AuNP. Meanwhile, without radiation, the AuNP showed minimal effect on the cancer cells. These findings provide in vitro evidence that AuNP may be employed as radiosensitizers during continuous LDR brachytherapy. From the Clinical Editor: In this basic science paper, the application of gold nanoparticles as radiosensitizing agents for low dose rate gamma radiation therapy is discussed, demonstrating efficacy in cell culture models. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:25 / 27
页数:3
相关论文
共 20 条
[1]   Residual γH2AX foci as an indication of lethal DNA lesions [J].
Banath, Judit P. ;
Klokov, Dmitry ;
MacPhail, Susan H. ;
Banuelos, C. Adriana ;
Olive, Peggy L. .
BMC CANCER, 2010, 10
[2]   Gold Nanoparticles as Radiation Sensitizers in Cancer Therapy [J].
Chithrani, Devika B. ;
Jelveh, Salomeh ;
Jalali, Farid ;
van Prooijen, Monique ;
Allen, Christine ;
Bristow, Robert G. ;
Hill, Richard P. ;
Jaffray, David A. .
RADIATION RESEARCH, 2010, 173 (06) :719-728
[3]   The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/x-ray sources [J].
Cho, Sang Hyun ;
Jones, Bernard L. ;
Krishnan, Sunil .
PHYSICS IN MEDICINE AND BIOLOGY, 2009, 54 (16) :4889-4905
[4]   The use of gold nanoparticles to enhance radiotherapy in mice [J].
Hainfeld, JF ;
Slatkin, DN ;
Smilowitz, HM .
PHYSICS IN MEDICINE AND BIOLOGY, 2004, 49 (18) :N309-N315
[5]  
Herold DM, 2000, INT J RADIAT BIOL, V76, P1357, DOI 10.1080/09553000050151637
[6]   Gold nanoparticles as novel agents for cancer therapy [J].
Jain, S. ;
Hirst, D. G. ;
O'Sullivan, J. M. .
BRITISH JOURNAL OF RADIOLOGY, 2012, 85 (1010) :101-113
[7]   Nuclear Targeting of Gold Nanoparticles in Cancer Cells Induces DNA Damage, Causing Cytokinesis Arrest and Apoptosis [J].
Kang, Bin ;
Mackey, Megan A. ;
El-Sayed, Mostafa A. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2010, 132 (05) :1517-+
[8]   LETHALITY OF AUGER ELECTRONS FROM THE DECAY OF BR-77 IN THE DNA OF MAMMALIAN-CELLS [J].
KASSIS, AI ;
ADELSTEIN, SJ ;
HAYDOCK, C ;
SASTRY, KSR ;
MCELVANY, KD ;
WELCH, MJ .
RADIATION RESEARCH, 1982, 90 (02) :362-373
[9]  
KASSIS AI, 1983, J NUCL MED, V24, P1164
[10]   Phosphorylated histone H2AX in relation to cell survival in tumor cells and xenografts exposed to single and fractionated doses of X-rays [J].
Klokov, Dmitry ;
MacPhail, Susan M. ;
Banath, Judit P. ;
Byrne, James P. ;
Olive, Peggy L. .
RADIOTHERAPY AND ONCOLOGY, 2006, 80 (02) :223-229